Skip to content

The Evaluation of a CONSORT Based Online Writing Tool

The Evaluation of a CONSORT Based Online Writing Tool: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02127567
Acronym
COBWEB
Enrollment
41
Registered
2014-04-30
Start date
2014-04-30
Completion date
2014-07-31
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focus of Study = Medical Writing

Keywords

medical writing, reporting, randomized controlled trial

Brief summary

Introduction: Inadequate reporting is a frequent cause of waste of research. For example, essential information for evaluating the risk of bias such as the method of randomization is lacking in 75% of published randomized controlled trials (RCTs), and over 30% of reports do not provide sufficient details to allow replication of the treatment evaluated in the trial in clinical practice. To overcome this issue, the CONSORT statement, an evidence-based, minimum set of recommendations for reporting RCTs was developed in 1996. These guidelines have since been updated in 2001 and more recently in 2010. In addition, extensions to the main CONSORT statement have been developed to give additional guidance for RCTs with specific designs (eg cluster), data (eg harm), and interventions (eg nonpharmacologic treatments). Many journals endorse the CONSORT statement. Some journals provide recommendations to authors to follow the CONSORT guidelines and some editors enforce the use of the CONSORT guidelines by requesting authors to submit a checklist in either the submission or acceptance stage. Nevertheless, inadequate reporting remains. Our objective is to evaluate the impact of the CONSORT based online writing tool on the completeness of reporting.

Detailed description

Context Inadequate reporting is a frequent cause of waste of research. For example, essential information for evaluating the risk of bias such as the method of randomization is lacking in 75% of published randomized controlled trials (RCTs), and over 30% of reports do not provide sufficient details to allow replication of the treatment evaluated in the trial in clinical practice. To overcome this issue, the CONSORT statement, an evidence-based, minimum set of recommendations for reporting RCTs was developed in 1996. These guidelines have since been updated in 2001 and more recently in 2010. In addition, extensions to the main CONSORT statement have been developed to give additional guidance for RCTs with specific designs (eg cluster), data (eg harm), and interventions (eg nonpharmacologic treatments). Many journals endorse the CONSORT statement. Some journals provide recommendations to authors to follow the CONSORT guidelines and some editors enforce the use of the CONSORT guidelines by requesting authors to submit a checklist in either the submission or acceptance stage. Nevertheless, inadequate reporting remains. Hypothesis We hypothesize that to improve reporting, the CONSORT guidelines must be implemented at the stage of the writing of the manuscript instead of at the stage of journal submission or peer review process. We developed a CONSORT based online writing tool to improve the completeness of reporting. This tool focuses on some domains of the methods section of a 2-arm parallel group randomized controlled trial evaluating pharmacologic or nonpharmacologic treatment. Objective Our objective is to evaluate the impact of the CONSORT based online writing tool on the completeness of reporting. Methods Study design: We will perform a split-manuscript randomized controlled trial, adapted from the split-body design. We will consider 6 domains of the methods section: trial design, randomization, blinding, participants, interventions, and outcomes. The unit of randomization will be the domain and the allocation ratio 1:1. Each study participant will receive the experimental intervention (the tool) for 3 of the 6 domains and the control intervention (no tool) for thther 3 domains. Participants: Masters and doctoral students Intervention: The use of the online writing tool for writing the methods section of an article from an RCT protocol. Comparator: The writing the methods section of an article from an RCT protocol with no specific support. Primary outcome: The primary outcome will be the average score for completeness of reporting. Number of participants expected: 40

Interventions

OTHERonline writing tool

The writing tool contained the main CONSORT item and extension items for non pharmacological treatments along with bullet points indicating key elements to report from the explanation and elaboration publications of the CONSORT. Participants were also instructed to detail information they felt important to report but that was not available in the study protocol they were provided.

OTHERwriting with no specific support

The control tool simply provided the domain or section heading with a space too write. Similar to for the experimental intervention, participants were to indicate information they felt important to report but unavailable in the provided study protocols.

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults * Masters or doctoral students

Exclusion criteria

* not in the field of medical research * not adults * no masters or doctoral level education

Design outcomes

Primary

MeasureTime frameDescription
The Primary Outcome Will be the Average Score for Completeness of Reporting on a Scale of 0-10.one time measure after a four-hour writing sessionCompleteness of reporting will be determined according to a grading rubric individualized to each study protocol, 0 being the lowest and 10 the highest

Secondary

MeasureTime frameDescription
The Score for Completeness of Reporting for Blindingone time measure after a four-hour writing sessionon a scale from 0 to 10, 0 being the lowest and 10 the highest
The Score for Completeness of Reporting for Participantsone time measure after a four-hour writing sessionon a scale from 0 to 10, 0 being the lowest and 10 the highest
The Score for Completeness of Reporting for Interventionsone time measure after a four-hour writing sessionon a scale from 0 to 10, 0 being the lowest and 10 the highest
The Score for Completeness of Reporting for Randomizationone time measure after a four-hour writing sessionThe score for completeness of reporting (0-10) for the manuscript section randomization, 0 being the lowest and 10 the highest
The Score for Completeness of Reporting for Trial Designone time measure after a four-hour writing sessionon a scale from 0 to 10, 0 being the lowest and 10 the highest
Average Score for Completeness of Reporting of Essential Elementsone time four hour writing sessionCompleteness of reporting scores calculated based on essential elements to report, on a scale from 0 to 10, 0 being the lowest and10 the highest
The Score for Completeness of Reporting for Outcomesone time measure after a four-hour writing sessionon a scale from 0 to 10, 0 being the lowest and 10 the highest

Countries

France

Participant flow

Participants by arm

ArmCount
All Participants41
Total41

Baseline characteristics

CharacteristicAll Participants
Age, Continuous29 years
Comfortable with English26 Participants
Education
doctoral students
14 participants
Education
masters students
27 participants
Experience writing RCTs7 Participants
Familiar with guidelines
Familiar with guidelines
24 participant
Familiar with guidelines
Not familiar with guidelines
17 participant
Frequency reading RCTs
More than once a year
30 Participants
Frequency reading RCTs
once a month
6 Participants
Frequency reading RCTs
Once a week
5 Participants
Previously involved in RCTs18 Participants
Sex: Female, Male
Female
24 Participants
Sex: Female, Male
Male
17 Participants
Taught about RCTs38 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 410 / 41

Outcome results

Primary

The Primary Outcome Will be the Average Score for Completeness of Reporting on a Scale of 0-10.

Completeness of reporting will be determined according to a grading rubric individualized to each study protocol, 0 being the lowest and 10 the highest

Time frame: one time measure after a four-hour writing session

ArmMeasureValue (MEAN)Dispersion
Online Writing Tool, Experimental ArmThe Primary Outcome Will be the Average Score for Completeness of Reporting on a Scale of 0-10.7.1 units on a scaleStandard Deviation 1.2
Writing With no Specific Support, Control ArmThe Primary Outcome Will be the Average Score for Completeness of Reporting on a Scale of 0-10.5.0 units on a scaleStandard Deviation 1.6
p-value: <0.00195% CI: [1.5, 2.7]Mixed Models Analysis
Secondary

Average Score for Completeness of Reporting of Essential Elements

Completeness of reporting scores calculated based on essential elements to report, on a scale from 0 to 10, 0 being the lowest and10 the highest

Time frame: one time four hour writing session

ArmMeasureValue (MEAN)Dispersion
Online Writing Tool, Experimental ArmAverage Score for Completeness of Reporting of Essential Elements7.8 units on a scaleStandard Deviation 1.6
Writing With no Specific Support, Control ArmAverage Score for Completeness of Reporting of Essential Elements6.4 units on a scaleStandard Deviation 2.3
p-value: 0.00295% CI: [0.5, 2.3]Mixed Models Analysis
Secondary

The Score for Completeness of Reporting for Blinding

on a scale from 0 to 10, 0 being the lowest and 10 the highest

Time frame: one time measure after a four-hour writing session

ArmMeasureValue (MEAN)Dispersion
Online Writing Tool, Experimental ArmThe Score for Completeness of Reporting for Blinding6.9 units on a scaleStandard Deviation 2.4
Writing With no Specific Support, Control ArmThe Score for Completeness of Reporting for Blinding6.2 units on a scaleStandard Deviation 2.3
p-value: 0.4495% CI: [-0.7, 2]Mixed Models Analysis
Secondary

The Score for Completeness of Reporting for Interventions

on a scale from 0 to 10, 0 being the lowest and 10 the highest

Time frame: one time measure after a four-hour writing session

ArmMeasureValue (MEAN)Dispersion
Online Writing Tool, Experimental ArmThe Score for Completeness of Reporting for Interventions7.1 units on a scaleStandard Deviation 1.5
Writing With no Specific Support, Control ArmThe Score for Completeness of Reporting for Interventions5.3 units on a scaleStandard Deviation 2
p-value: <0.0195% CI: [0.7, 2.9]Mixed Models Analysis
Secondary

The Score for Completeness of Reporting for Outcomes

on a scale from 0 to 10, 0 being the lowest and 10 the highest

Time frame: one time measure after a four-hour writing session

ArmMeasureValue (MEAN)Dispersion
Online Writing Tool, Experimental ArmThe Score for Completeness of Reporting for Outcomes6.1 units on a scaleStandard Deviation 2.1
Writing With no Specific Support, Control ArmThe Score for Completeness of Reporting for Outcomes6.4 units on a scaleStandard Deviation 3
p-value: 0.7895% CI: [-2, 1.3]Mixed Models Analysis
Secondary

The Score for Completeness of Reporting for Participants

on a scale from 0 to 10, 0 being the lowest and 10 the highest

Time frame: one time measure after a four-hour writing session

ArmMeasureValue (MEAN)Dispersion
Online Writing Tool, Experimental ArmThe Score for Completeness of Reporting for Participants6.7 units on a scaleStandard Deviation 2
Writing With no Specific Support, Control ArmThe Score for Completeness of Reporting for Participants4.5 units on a scaleStandard Deviation 2.4
p-value: <0.0195% CI: [0.8, 3.6]Mixed Models Analysis
Secondary

The Score for Completeness of Reporting for Randomization

The score for completeness of reporting (0-10) for the manuscript section randomization, 0 being the lowest and 10 the highest

Time frame: one time measure after a four-hour writing session

ArmMeasureValue (MEAN)Dispersion
Online Writing Tool, Experimental ArmThe Score for Completeness of Reporting for Randomization8.4 units on a scaleStandard Deviation 2.4
Writing With no Specific Support, Control ArmThe Score for Completeness of Reporting for Randomization4.6 units on a scaleStandard Deviation 2.9
p-value: <0.0195% CI: [1.1, 4.4]Mixed Models Analysis
Secondary

The Score for Completeness of Reporting for Trial Design

on a scale from 0 to 10, 0 being the lowest and 10 the highest

Time frame: one time measure after a four-hour writing session

ArmMeasureValue (MEAN)Dispersion
Online Writing Tool, Experimental ArmThe Score for Completeness of Reporting for Trial Design8.1 units on a scaleStandard Deviation 2.3
Writing With no Specific Support, Control ArmThe Score for Completeness of Reporting for Trial Design2.7 units on a scaleStandard Deviation 1.9
p-value: <0.0195% CI: [4.1, 6.7]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026